Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nang Kuang Pharmaceutical Co., Ltd. (1752:TWSE), powered by AI.
Nang Kuang Pharmaceutical Co., Ltd. is currently trading at $35.55. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nang Kuang Pharmaceutical Co., Ltd. on Alpha Lenz.
Nang Kuang Pharmaceutical Co., Ltd.'s P/E ratio is 14.7.
“Nang Kuang Pharmaceutical Co., Ltd. trades at a P/E of 14.7 (undervalued) with solid ROE of 10.1%.”
Ask for details →Nang Kuang Pharmaceutical Co., Ltd. operates as a prominent entity within the pharmaceutical industry, specializing in the development, manufacturing, and sale of health-focused products. The company plays a vital role in the healthcare sector by producing a wide range of pharmaceuticals, including prescription drugs, over-the-counter medications, and biopharmaceuticals. It is known for its commitment to research and development, consistently striving to enhance its product offerings and address various therapeutic needs. Nang Kuang Pharmaceutical significantly impacts both domestic and international markets by exporting its high-quality products across the globe. Its operations support critical health infrastructures and contribute to the availability of essential medicine in various regions, reinforcing its importance in the global pharmaceutical supply chain. With a focus on innovation and quality, Nang Kuang Pharmaceutical Co., Ltd. remains a key player in addressing evolving healthcare challenges and requirements.
“Nang Kuang Pharmaceutical Co., Ltd. trades at a P/E of 14.7 (undervalued) with solid ROE of 10.1%.”
Ask for details →Nang Kuang Pharmaceutical Co., Ltd. (ticker: 1752) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). Market cap is $3.6B.
The current price is 35.55 with a P/E ratio of 14.75x and P/B of 1.48x.
ROE is 10.14% and operating margin is 13.98%. Annual revenue is $2.2B.